Page last updated: 2024-08-23

phenyl acetate and Brain Vascular Disorders

phenyl acetate has been researched along with Brain Vascular Disorders in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19907 (58.33)18.7374
1990's3 (25.00)18.2507
2000's0 (0.00)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bueno-Cavanillas, A; Hoxha, M; Lewis-Mikhael, AM1
Bu, Y; Choi, H; Jamakattel-Pandit, N; Kim, H; Kim, J; Kim, MY; Leem, KH; Moon, S1
BRENNER, H1
BOVI, A1
GIANNINI, G; INVERNIZZI, G1
Chanu, B1
Averbuch-Heller, L; Collins, SD; Leigh, RJ; Rottach, KG; Stahl, JS; von Maydell, RD1
Nara, Y; Sawamura, M; Yamori, Y1
Barsan, WG; Dimlich, RV; Dronen, SC; Hedges, JR; Syverud, SA1
Hörmann, M1
Broicher, H; Schmidt, H1
Duus, P; Gleim, F; Herrschaft, H1

Reviews

1 review(s) available for phenyl acetate and Brain Vascular Disorders

ArticleYear
Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106

    Topics: Acetates; Animals; Cardiovascular Diseases; Cardiovascular System; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Risk Factors; Sulfides

2018

Trials

1 trial(s) available for phenyl acetate and Brain Vascular Disorders

ArticleYear
[Inhibitors of GPIIb/IIIa platelet receptors].
    Archives des maladies du coeur et des vaisseaux, 1999, Volume: 92, Issue:7

    Topics: Abciximab; Acetates; Antibodies, Monoclonal; Cerebrovascular Disorders; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombocytopenia; Tirofiban; Tyrosine

1999

Other Studies

10 other study(ies) available for phenyl acetate and Brain Vascular Disorders

ArticleYear
Key compound groups for the neuroprotective effect of roots of Polygonum cuspidatum on transient middle cerebral artery occlusion in Sprague-Dawley rats.
    Natural product research, 2010, Volume: 24, Issue:13

    Topics: 1-Butanol; Acetates; Animals; Anthraquinones; Cerebrovascular Disorders; Chemical Fractionation; Chromatography, High Pressure Liquid; Fallopia japonica; Hexanes; Lipid Peroxidation; Male; Neuroprotective Agents; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rotarod Performance Test; Stilbenes

2010
[On the value of dimethylaminoethyl p-chlorophenoxyacetate in the treatment of injuries and diseases of the brain].
    Wiener medizinische Wochenschrift (1946), 1962, May-05, Volume: 112

    Topics: Acetates; Brain; Brain Neoplasms; Central Nervous System Stimulants; Cerebrovascular Disorders

1962
[Effects of intracarotid-injected diisopropylammonium dichloroethanoate in vasculopatic subjects. Angiographic and rheographic observations].
    Giornale di psichiatria e di neuropatologia, 1963, Volume: 91

    Topics: Acetates; Ammonium Compounds; Cerebrovascular Disorders; Humans; Quaternary Ammonium Compounds; Vascular Diseases

1963
[DICHLOROETHANOATE "DIEDI" IN CEREBRAL VASCULOPATHIES].
    Minerva medica, 1964, Dec-19, Volume: 55

    Topics: Acetates; Ammonium Compounds; Cerebrovascular Disorders; Drug Therapy; Geriatrics; Humans; Papaverine; Quaternary Ammonium Compounds

1964
A pilot study of gabapentin as treatment for acquired nystagmus.
    Neuro-ophthalmology (Aeolus Press), 1996, Volume: 16, Issue:2

    Topics: Acetates; Adult; Amines; Anticonvulsants; Brain Stem; Cerebrovascular Disorders; Cyclohexanecarboxylic Acids; Eye Movements; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Multiple Sclerosis; Nystagmus, Pathologic; Pilot Projects; Reflex, Vestibulo-Ocular; Vision Disorders; Visual Acuity

1996
Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
    The Journal of biological chemistry, 1992, Mar-25, Volume: 267, Issue:9

    Topics: Acetates; Animals; Carboxy-Lyases; Cerebrovascular Disorders; Cholesterol; Hydroxymethylglutaryl CoA Reductases; In Vitro Techniques; Kinetics; Liver; Male; Mevalonic Acid; Organ Specificity; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity

1992
Effects of dichloroacetate in spinal stroke in the rabbit.
    Life sciences, 1987, Aug-31, Volume: 41, Issue:9

    Topics: Acetates; Animals; Blood Glucose; Cerebrovascular Disorders; Dichloroacetic Acid; Lactates; Lactic Acid; Male; Movement; Rabbits; Spinal Cord; Spinal Cord Diseases; Time Factors

1987
[Drug therapy of aphasic disorders following brain injury and cerebral vascular involvement].
    Fortschritte der Medizin, 1973, Jan-25, Volume: 91, Issue:3

    Topics: Acetates; Aphasia; Central Nervous System Stimulants; Cerebrovascular Disorders; Craniocerebral Trauma; Humans; Meclofenoxate; Prognosis

1973
[Clinical results after the treatment of cases of cerebral insufficiency with centrophenoxine (Helfergin)].
    Die Medizinische Welt, 1970, Aug-15, Volume: 33

    Topics: Acetates; Aged; Aging; Central Nervous System Stimulants; Cerebrovascular Disorders; Female; Humans; Male; Meclofenoxate; Middle Aged

1970
[The effect of centrophenoxine on regional cerebral blood flow in man (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1974, Aug-30, Volume: 99, Issue:35

    Topics: Acetates; Adult; Aged; Aphasia; Apraxias; Blood Pressure; Brain; Carotid Artery, Internal; Cerebrovascular Circulation; Cerebrovascular Disorders; Female; Hemiplegia; Humans; Injections, Intravenous; Intracranial Arteriosclerosis; Isotope Labeling; Male; Meclofenoxate; Middle Aged; Time Factors; Xenon

1974